3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market

By David Jagielski, CPA – Apr 15, 2026 at 11:15AM ESTKey PointsThe stocks listed here offer investors high dividend yields, well above the S&P 500 average.They also outperformed the index back in 2022, when the market crashed.Dividend stocks may not be flashy investments, but they can be dependable ones, particularly if you're worried about the market. They can generate recurring income for your portfolio and help boost your overall returns, which can be important in a downturn. Three stocks that can be compelling options for investors today are AbbVie (ABBV 0.83%), Chevron (CVX 0.96%), and Vici Properties (VICI 0.95%). They offer high yields, have strong fundamentals, and these stocks all outperformed the S&P 500 back in 2022, when the market went into a tailspin. Here's a closer look at why you may want to consider loading up on these solid dividend stocks today. Image source: Getty Images. AbbVie Drugmaker AbbVie is a top healthcare company to invest in, regardless of economic conditions. It has a broad portfolio of drugs, which helps position it for strong long-term growth. Its revenue rose by about 9% last year, driven by strong results from its immunology and neuroscience segments. But the business also has drugs in other areas, including oncology and eye care. It also owns Botox. Its operations are broad and diverse, making AbbVie one of the best healthcare stocks to own. Its stability has enabled it to pay dividends and raise them consistently over the years. Currently, the stock yields 3.3%, which is close to three times the S&P 500 average of 1.2%. It's an excellent payout for a stock with tremendous upside potential. Based on analyst expectations, AbbVie's stock trades at a forward price-to-earnings multiple of just 14, making it an attractive value buy today. ExpandNYSE: ABBVAbbVieToday's Change(-0.83%) $-1.73Current Price$206.80Key Data PointsMarket Cap$372BDay's Range$205.63 - $209.8252wk Range$168.54 - $244.81Volume1.5MAvg Vol7.1MGross Margin70.12%Dividend Yield3.16% Back in 2022, when the S&P 500 crashed by 19%, AbbVie rose by a similar amount, defying the broader market bearishness. It could once again be a safe-haven investment for investors to turn to if there's a near-term crash, given not only its high dividend but also its attractive valuation. Chevron Investing in oil and gas stocks can be a good move for dividend investors, particularly when oil prices are as high as they are now. In 2022, when the markets crashed, oil prices were also elevated, and back then, Chevron's stock rallied by 53%, and that's without factoring in its dividend. This year, the stock is up around 23%. While that has an inverse effect on its yield, Chevron's stock still pays 3.8%, which can be highly valuable for dividend investors. It has also been increasing its payout for decades, giving you plenty of incentive to just remain invested for the long haul. ExpandNYSE: CVXChevronToday's Change(-0.96%) $-1.80Current Price$185.22Key Data PointsMarket Cap$373BDay's Range$184.05 - $187.2452wk Range$132.33 - $214.71Volume147KAvg Vol13MGross Margin14.66%Dividend Yield3.69% The business can experience volatility due to oil prices, but its financial results have remained strong: Chevron has generated an operating profit of at least $16 billion in each of the past four years, and its annual free cash flow has also been above $15 billion over that time frame. It's a solid investment to hold on to, as the stock has proven to be a reliable source of dividend income across a wide range of economic conditions.

Vici Properties Vici Properties is the highest-yielding stock on this list, paying 6.3%. The real estate investment trust (REIT) owns various properties, including casinos, racetracks, golf courses, bowling alleys, and hotels. The company generated strong and steady results last year, with revenue rising by 4% to just over $4 billion, and net income climbing by a similar percentage, to $2.8 billion. By having a diverse mix of properties, the REIT can be in a good position to do well even if the economy is struggling, and it was indeed a safe investment in 2022 when the market crashed. That year, shares of Vici Properties rose by a little less than 8%. It was a good, steady performance for the REIT. And when combined with its high dividend, its total returns were around 13%. ExpandNYSE: VICIVici PropertiesToday's Change(-0.95%) $-0.27Current Price$28.09Key Data PointsMarket Cap$30BDay's Range$27.95 - $28.3352wk Range$26.55 - $34.01Volume70KAvg Vol9.5MGross Margin99.24%Dividend Yield6.29% This year, the stock has been underperforming the S&P 500 slightly, as it's up around just 1%. But with a strong dividend and the potential to be a safe-haven investment under more challenging market conditions, it can prove to be an underrated buy right now. Vici's dividend, while high, doesn't appear to be in any danger as the REIT's funds from operations per share came in at $2.61 last year, comfortably higher than the rate of its annual dividend per share -- $1.80. For dividend investors, this may be one of the better stocks to buy right now.Read NextApr 14, 2026 •By Prosper Junior BakinyCould AbbVie Crash Lilly's Weight‑Loss Party?Apr 13, 2026 •By Eric VolkmanS&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend.Apr 8, 2026 •By David Jagielski, CPA3 Absurdly Cheap Dividend Stocks to Buy in April 2026Apr 7, 2026 •By Thomas NielThis Pharma Dividend Has Been Raised Every Single Year for Over a DecadeApr 7, 2026 •By David Jagielski, CPAShould You Buy AbbVie Stock Before April 29?Apr 6, 2026 •By Lyle DalyThe Largest Healthcare Companies by Market Cap in April 2026About the AuthorDavid Jagielski, CPA, has been a contributing Motley Fool stock market analyst covering healthcare, consumer staples, consumer discretionary, and technology stocks since 2017. David has more than 10 years of experience in finance roles across businesses of different sizes and sectors. He holds a Certified Public Accountant designation in Canada.TMFdjagielskiStocks MentionedAbbVieNYSE: ABBV$206.83(-0.81%)-$1.70ChevronNYSE: CVX$185.02(-1.07%)-$2.00Vici PropertiesNYSE: VICI$28.04(-1.15%)-$0.33*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.